Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/1996
11/14/1996WO1996028148A3 Use of a r-nsaid in a protective composition for the treatment of colorectal cancer
11/14/1996WO1996015148A3 Low molecular weight peptidomimetic growth hormone secretagogues
11/14/1996DE19517448A1 Neue Benzothiazole und Benzoxazole, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung New benzothiazoles and benzoxazoles, pharmaceutical compositions containing them and their use, and processes for their preparation
11/14/1996DE19517430A1 Pharmazeutische Darreichungsform von Parathormon mit einer zwei- bis sechsstündigen Wirkstoff-Freisetzungsperiode The pharmaceutical dosage form of parathyroid hormone with a two- to six-hour drug release period
11/14/1996CA2221035A1 Tripeptidylpeptidase inhibitors
11/14/1996CA2220538A1 .beta.-adrenergic agonists
11/14/1996CA2220399A1 .beta.-adrenergic agonists
11/14/1996CA2219877A1 Treatment for inhibiting the progression of autoimmune disease
11/14/1996CA2218529A1 Nucleic acids for treating obesity
11/14/1996CA2217860A1 Benzothiazoles and benzoxazoles, pharmaceutical compositions containing these compounds and their use and processes for preparing them
11/14/1996CA2217850A1 Peptide compounds which inhibit metalloproteinase and tnf liberation, and their therapeutic use
11/13/1996EP0742203A2 Vitamin D compounds and method of preparing these compounds
11/13/1996EP0741785A1 Methods and compositions for stimulating bone cells
11/13/1996EP0741724A1 Neuroprotective chroman compounds
11/13/1996EP0741709A1 Aromatic 2-amino-imidazole derivatives as alpha-2a adrenoceptor agonists
11/13/1996EP0741697A1 Amino acid derivatives and their use as phospholipase a2 inhibitors
11/13/1996EP0741578A1 Human growth hormone
11/13/1996CN1135718A Method and products for controlling immune responses in mammals
11/13/1996CN1135480A Alkyl heterocyclic compound and preparation method thereof, and medicinal composition containing that kind of compound
11/12/1996US5574071 Administering phenylalkylamino ketones
11/12/1996US5574051 Hypoglycemic
11/12/1996US5574047 Methods of inhibiting imperfect tissue repair
11/12/1996US5574024 Methylene phosphonoalkylphosphinates, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism
11/12/1996US5573781 Injectable fatty acid ester and cytostatic agent
11/12/1996CA2068438C Essential pure human parathyroid hormone
11/11/1996EP0748792A4 Calcium ketopantothenate with acetylating properties
11/10/1996CA2175881A1 Vitamin d compounds and methods of preparing these compounds
11/08/1996EP0748793A4 Ketopanthenol with acetylating properties
11/07/1996WO1996034948A1 Monoclonal antibody reactive with human-origin cetp and method of quantifying human-origin cetp
11/07/1996WO1996034943A1 Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states
11/07/1996WO1996034888A1 Modulation of cholesteryl ester transfer protein (cetp) activity
11/07/1996WO1996034885A2 Biologically active peptide fragments of ob protein
11/07/1996WO1996034870A1 Azacycloalcane derivatives, preparation thereof and their applications in therapy
11/07/1996WO1996034858A1 Nicotinic acid esters and pharmaceutical compositions containing them
11/07/1996WO1996034855A1 Fatty acid esters as bioactive compounds
11/07/1996WO1996034846A1 1,3-propane diol derivatives as bioactive compounds
11/07/1996CA2220156A1 Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states
11/07/1996CA2220015A1 Azacycloalcane derivatives, preparation thereof and their applications in therapy
11/06/1996EP0741187A2 Recombinant obese (Ob) proteins
11/06/1996EP0741133A2 Adhesion receptor antagonists
11/06/1996EP0740937A2 Use of retinoids for the manufacture of a pharmaceutical or cosmetic composition
11/06/1996EP0740936A2 Use of benzopyran derivatives for the manufacture of medicaments for the treatment of diseases connected with the sodium independent Cl-/HCO3- exchanger
11/06/1996EP0740679A1 Crosslinked polymeric ammonium salts
11/06/1996EP0590034B1 Method for determining the presence of diabetes associated antibodies or islet cell directed antibodies
11/06/1996CN1134938A Novel alkylated (hetero) cyclic compounds, process for their prepn. and pharmaceutical compositions contg. same
11/06/1996CA2175747A1 Benzopyrane derivatives used for preparing pharmaceutical compositions used in the treatment of pathology related to na+ independent cl-/hco3- exchanger
11/06/1996CA2175298A1 Recombinant obese (ob) proteins
11/05/1996US5571816 Pyrimidines
11/05/1996US5571807 Calcium antagonists, treatment of angina and hypertension
11/05/1996US5571802 Method of treating post menopausal osteoporosis with hexafluro-vitamin D
11/05/1996US5571783 Composition and method for treating patients with hepatic disease
11/05/1996US5571507 Methods of treating diabetes
11/05/1996CA2098102C Alteration of rate and character of hair growth
10/1996
10/31/1996WO1996034104A1 Antagonists of human interleukin-6 that are totally incapable of binding gp 130, and their use in the preparation of pharmaceutical compounds
10/31/1996WO1996034100A1 Immortalised cell lines from human adipose tissue, process for preparing same and applications thereof
10/31/1996WO1996034095A1 Human tumor necrosis factor receptors
10/31/1996WO1996033724A2 Selective modulators of peroxisome proliferator activated receptor-gamma, and methods for the use thereof
10/31/1996WO1996033703A2 S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy
10/31/1996WO1996029063A3 Pinitol and derivatives thereof for the treatment of metabolic disorders
10/31/1996CA2219996A1 Immortalised cell lines from human adipose tissue, process for preparing same and applications thereof
10/31/1996CA2218955A1 Selective modulators of peroxisome proliferator activated receptor-gamma, and methods for the use thereof
10/31/1996CA2217696A1 S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy
10/30/1996EP0739892A2 Chromone derivatives
10/30/1996EP0739887A1 Cyclohexane compounds, process for their preparation and pharmaceutical compositions containing them
10/30/1996EP0739488A1 Antagonists to insulin receptor tyrosine kinase inhibitor
10/30/1996EP0739355A1 Kallikrein-inhibiting "kunitz domain" proteins and analogues thereof
10/30/1996EP0739210A1 Methods and compositions for the treatment of a host with a cellular proliferative disease
10/30/1996EP0739207A1 Enteral formula with ribo-nucleotides
10/30/1996EP0695301B1 Indole derivatives as 5-ht1-like agonists for use in migraine
10/30/1996EP0532595B1 The pharmacological use of certain cystine derivatives
10/30/1996CN1134724A Insulin-secreting cell lines, methods of production and use
10/30/1996CN1134699A Succinamic acid compound, process for producing the same, and use thereof
10/30/1996CN1134669A Use of thiazolidinediones to prevent or delay onset of NIDDM
10/29/1996US5569674 Heteroacetic acid derivatives
10/29/1996US5569672 Human and animal growth promoters; calcium pseudomonate
10/29/1996US5569647 Angiopeptin cyclopeptide compounds
10/29/1996CA2073873C Use of 3-guanidinopropionic acid in the treatment and prevention of metabolic disorders
10/28/1996CA2174892A1 Cyclohexane compounds; process for preparing the same and pharmaceutical compositions containing them
10/25/1996EP0712936A4 Low-molecular dna from sturgeon mult, a method of obtaining the dna and a pharmaceutical preparation based on it
10/24/1996WO1996033193A1 Novel triazolones as apolipoprotein-b synthesis inhibitors
10/24/1996WO1996033159A1 Cyclobutane derivatives as inhibitors of squalene synthase and protein farnesyltransferase
10/24/1996CA2218597A1 Cyclobutane derivatives as inhibitors of squalene synthase and protein farnesyltransferase
10/24/1996CA2217632A1 Novel triazolones as apolipoprotein-b synthesis inhibitors
10/23/1996EP0738727A1 1,4-benzoxazine-2-acetic acid compound, process for producing the same, and use thereof
10/23/1996EP0738475A1 Alpha-glucosidase inhibitor, composition principally comprising sugar and containing the same, sweetener, food and feed
10/23/1996EP0738267A1 Acetylenes disubstituted with a phenyl or heteroaryl group and a 2-oxochromanyl, 2-oxothiochromanyl or 2-oxo-1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity
10/23/1996EP0738153A1 Synthetic insulin mimetic substances
10/23/1996EP0738151A1 Treatment using arachidonic acid metabolite and particulate formulations
10/23/1996EP0738147A1 Application of riluzole in the treatment of mitochondrial diseases
10/23/1996EP0738107A1 Inhibitors of fatty acid synthesis as antimicrobial agents
10/23/1996EP0579616B1 Method for extracting a biological substance from lepidoptera larvas and substance thus obtained
10/23/1996EP0541524B1 Food and feedstuff
10/23/1996CN1134111A Method of using insulin-like growth factor binding proteins
10/23/1996CN1134110A Method for regulating gastrointestinal motility
10/22/1996US5567841 α-phosphonosulfonate squalene synthetase inhibitors and method
10/22/1996US5567828 For treatment of post-menopausal diseases, i.e., osteoporosis, cardiovascular disorders, cancer
10/22/1996US5567820 Therapy for bone diseases
10/22/1996US5567725 Antidiabetic agent
10/22/1996US5567715 1-benzothiophene derivatives
10/22/1996US5567714 Methods of treating obesity by inhibiting physiological conditions associated with an excess of neuropeptide Y
1 ... 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 ... 1298